Abstract Topics

  • Biomarkers in LSDs
  • Controversies in LSDs (newborn screening, PGD and role of patient reported outcome)
  • Neuronopathic and Non-Neuronopathic LSDs
  • Innovation in Therapeutics
  • GBA1 Related Parkinson
  • Molecular Genetics